2019

1. Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers

   The American journal of gastroenterology, Vol. 114, Núm. 5, pp. 771-776

2. Increased risk of thiopurine-related adverse events in elderly patients with IBD

   Alimentary Pharmacology and Therapeutics, Vol. 50, Núm. 7, pp. 780-788